NASDAQ:KURA - Kura Oncology, Inc.
$20.33
 $0.18
+0.89%
4:00PM EDT
2019-07-15
Kura Oncology, Inc., incorporated on November 16, 2007, is a clinical-stage biopharmaceutical company. The Company is engaged in discovering and developing personalized therapeutics for the treatment of solid tumors and blood cancers. The Company's segment is engaged in the discovery and development of personalized therapeutics for the treatment of solid tumors and blood cancers. The Company focuses on the development of small molecule product candidates that targets cell-signaling pathways, which drives the progression of certain cancers. The Company is developing its lead product candidate, tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. The Company's pipeline also includes over two preclinical programs. The Company is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with tumors that have mutations in or other dysregulation of the mitogen-activated protein kinase (MAPK), signaling pathway, including pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma.The Company's Tipifarnib is a small molecule inhibitor of protein farnesylation, a cell signaling process implicated in various cancer processes. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  KURA     avg for
industry  
  avg for
sector  
42 stocks weight:  84. 40   114. 77   204. 78  
42 stocks rank:  1. 69 K 1. 44 K 810. 33  
# analyst opinions:  7. 00   13. 59   13. 86  
mean recommendation:  1. 40   2. 12   2. 04  

quick ratio:  13. 65   5. 48   1. 89  
current ratio:  13. 80   5. 85   2. 40  

target price low:  25. 00   82. 72   115. 11  
target price avg:  30. 00   104. 42   138. 02  
target price high:  38. 00   130. 64   159. 47  
1-yr high:  21. 85   110. 27   142. 72  
last close:  20. 15   85. 12   126. 54  
50-day avg:  17. 70   86. 06   122. 35  
200-day avg:  15. 36   88. 76   121. 75  
1-yr low:  10. 60   69. 26   100. 63  
volume:  308. 69 K 3. 51 M 5. 53 M
50-day avg volume:  353. 92 K 3. 21 M 4. 22 M
200-day avg volume:  260. 44 K 3. 04 M 4. 75 M

1-day return:  -1. 56 % -0. 30 % -1. 01 %
this week return:  1. 77 % -2. 16 % -1. 35 %
12-wk return:  35. 14 % 3. 34 % 8. 69 %
52-wk return:  2. 61 % -1. 76 % 12. 22 %

enterprise value (EV):  619. 63 M 46. 50 B 123. 99 B
market cap:  769. 42 M 40. 77 B 109. 11 B
EBITDA:  -62. 84 M 4. 33 B 8. 19 B
enterprise multiple (EV/EBITDA):  -9. 86   5. 45   12. 05  
total debt:  8. 10 M 11. 27 B 17. 58 B
debt/equity:  5. 41   57. 36   120. 25  
net income (common):  -59. 78 M 2. 13 B 4. 27 B

shares outstanding:  38. 18 M 551. 08 M 1. 24 B
shares:  26. 94 M 559. 41 M 1. 22 B
shares short:  2. 11 M 11. 15 M 11. 94 M
shares short prior month:  2. 02 M 9. 31 M 11. 96 M
short ratio:  8. 17   5. 72   3. 43  
short % of float:  7. 35 % 6. 40 % 2. 65 %
total cash/share:  4. 33   11. 00   9. 23  
total cash:  165. 52 M 6. 03 B 6. 01 B
free cash flow:  -28. 36 M 3. 02 B 4. 96 B
operating cash flow:  -50. 05 M 3. 92 B 5. 99 B

book value:  3. 92   13. 02   27. 49  
price/book:  5. 14   4. 21   8. 80  
operating margins:  0. 00 % -380. 20 % -38. 44 %
EBITDA margins:  0. 00 % 13. 59 % 23. 24 %
profit margins:  0. 00 % 10. 94 % 14. 00 %
gross margins:  0. 00 % 36. 11 % 55. 16 %

1-yr max volatility:  0. 00 % --- ---
1-yr mean volatility:  0. 00 % 1. 50 % 1. 08 %

1-yr EPS:  -1. 63   2. 12   4. 26  
forward EPS:  -2. 03   3. 47   7. 14  
P/E:  -12. 39   2. 15   33. 17  
forward P/E:  -9. 93   -4. 03   17. 60  
PE/G:  2. 30   0. 54   0. 34  
growth:  -5. 39 % 263. 03 % 78. 34 %
earnings high:  -0. 40   0. 91   1. 70  
earnings avg:  -0. 42   0. 71   1. 58  
earnings low:  -0. 46   0. 48   1. 46  
revenue high:  -0. 00   2. 64 B 11. 26 B
revenue avg:  -0. 00   2. 58 B 11. 09 B
revenue low:  -0. 00   2. 54 B 10. 90 B
return on assets:  -25. 25 % -2. 31 % 5. 31 %
return on equity:  -43. 58 % -82. 48 % 135. 30 %

beta (1yr vs S&P500):  1. 61   1. 26   0. 91  
sharpe (1yr):  0. 27   0. 07   0. 77  

held % insiders:  19. 41 % 6. 08 % 3. 31 %
held % institutions:  84. 26 % 78. 36 % 69. 61 %

Research more with google or yahoo!
the data below are updated and re-published at 8pm EDT after each trading day

2019-07-14 : KURA
.    128.445 =       128.445 :: --> INITIAL WEIGHT <--
.    - 1.626 =       126.819 :: earnings per-share addition
.                               --> FUNDAMENTALS <--
.    x 2.258 =       286.388 :: P/E factor
.    x 0.932 =        266.82 :: PE/G factor
.    x 1.645 =       438.793 :: beta factor
.    x 0.736 =       322.955 :: sharpe factor
.    x 2.358 =       761.405 :: current ratio factor
.    x 1.039 =       790.937 :: quick ratio factor
.    x 1.059 =       837.945 :: short ratio factor
.    x 1.063 =       891.093 :: price-to-book factor
.    x 1.046 =         932.2 :: debt-to-equity factor
.                               --> PERFORMANCE <--
.    x 2.114 =      1970.657 :: sector+industry 1-year gains factor
.    x 1.033 =      2036.473 :: industry 12-weeks return factor
.    x 1.305 =      2658.154 :: industry 2-weeks return factor
.    x 0.995 =        2643.7 :: company one-year gains+dividend factor
.     x 3.72 =      9834.381 :: company 13 weeks' performance factor
.    x 1.646 =     16190.431 :: 5-day avg > 200-day avg
.    x 1.622 =     26263.623 :: 5-day avg > 50-day avg
.    x 1.152 =     30267.185 :: 50-day avg > 200-day avg
.    x 0.997 =     30173.379 :: "drift" penalty 3 days ago
.     / 1.97 =     15316.646 :: overall "drift" factor
.    x 0.898 =     13759.733 :: largest single-day jump factor
.        x 1 =     13759.733 :: volatility factor
.        x 1 =     13759.733 :: 42-day volatility factor
.    x 2.065 =     28410.266 :: notable returns + performance factor
.    x 2.541 =     72182.979 :: performance vs s&p500 factor
.     x 3.78 =    272870.801 :: inverse volume-to-price factor
.                               --> PROJECTIONS <--
.    x 0.798 =    217810.112 :: forward EPS factor
.    x 0.927 =    201839.413 :: forward P/E factor
.    x 1.182 =    238664.783 :: industry recommendation factor
.    x 3.121 =     744758.38 :: company recommendation factor
.    x 1.008 =    750454.547 :: factor historical industry gain for week 28
.    x 1.609 =   1207259.404 :: target low factor
.    x 1.233 =   1488617.835 :: target mean factor
.     x 1.04 =   1547463.448 :: target high factor
.   x 10.946 =  16939165.065 :: spline projection factor
.                               --> FINAL ADJUSTMENTS <--
.  quad root =        64.154 :: reduced for readability
.   + 20.243 =        84.397 :: add/subtract for investor sentiment
.                               --> FINAL WEIGHT <--
.                     84.397 :: FINAL WEIGHT for NASDAQ:KURA


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org